NDC-12 Cross-Industry Pilot - Phase 0 White Paper

Understand the industry-wide impacts of the NDC-12 transition

Facing growing limitations in the availability of labeler codes within the current National Drug Code (NDC) framework, the FDA had released a proposed NDC-12 Rule in 2022 and published the finalized version on March 5th 2026.

Cencora and NNIT have partnered with a cross-industry panel of experts to develop a strategy to aid supply chain partners, regulatory bodies, and standards organizations in evolving the thinking towards the magnitude and complexity of the transformation from a 10-digit to a 12-digit NDC and deliver findings, ideas, and recommendations within key deliverables to the industry and regulators.

This white paper shows you

Key findings and early insights how NDC-12 affects life sciences and healthcare as a whole
An education and analysis of the final rule with background and details
Findings from a broad supply chain analysis and industry impact assessment

Start your NDC-12 Journey

If your organization is preparing for the 12-digit NDC format and needs guidance on impact analysis, system updates, or transition planning, our team can help.

First name *

Last name *

Title *

Company *

Email *

Phone

Questions and/or needs

When you submit your inquiry to NNIT via the contact form, NNIT process the collected personal data in accordance with the Privacy Notice, where you can read more about your rights and how NNIT process your personal data.

The NDC-12 Cross-Industry Pilot: Key Findings & Insights From Phase 0

Understand the industry-wide impacts of the NDC-12 transition

This white paper shows you

Start your NDC-12 Journey

If your organization is preparing for the 12-digit NDC format and needs guidance on impact analysis, system updates, or transition planning, our team can help.